SE399252B - Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin - Google Patents

Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin

Info

Publication number
SE399252B
SE399252B SE7605853A SE7605853A SE399252B SE 399252 B SE399252 B SE 399252B SE 7605853 A SE7605853 A SE 7605853A SE 7605853 A SE7605853 A SE 7605853A SE 399252 B SE399252 B SE 399252B
Authority
SE
Sweden
Prior art keywords
argininÿ8
asparagin
desamino
vasopressin
procedure
Prior art date
Application number
SE7605853A
Other languages
English (en)
Swedish (sv)
Other versions
SE7605853L (sv
Inventor
J Mulder
L Carlsson
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE7605853A priority Critical patent/SE399252B/xx
Priority to GB21345/77A priority patent/GB1539317A/en
Priority to BE177844A priority patent/BE854968A/fr
Priority to JP5951077A priority patent/JPS537693A/ja
Priority to DE2723453A priority patent/DE2723453C2/de
Priority to US05/849,389 priority patent/US4148787A/en
Publication of SE7605853L publication Critical patent/SE7605853L/xx
Publication of SE399252B publication Critical patent/SE399252B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7605853A 1976-05-24 1976-05-24 Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin SE399252B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE7605853A SE399252B (sv) 1976-05-24 1976-05-24 Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
GB21345/77A GB1539317A (en) 1976-05-24 1977-05-20 Processes for the preparation of an antidiuretically active vasopressin
BE177844A BE854968A (fr) 1976-05-24 1977-05-24 Desamino-asparagine4-d-arginine8-vasopressine antidiuretique
JP5951077A JPS537693A (en) 1976-05-24 1977-05-24 Production of desaminoo asparagineeddalgininee basoblesine with antii uretic action
DE2723453A DE2723453C2 (de) 1976-05-24 1977-05-24 1-Desamino-asparagin↑4↑-D-arginin↑8↑-vasopressin, Verfahren zu seiner Herstellung sowie dieses Peptid enthaltende antidiuretische Arzneimittel
US05/849,389 US4148787A (en) 1976-05-24 1977-11-08 Antidiuretically effective polypeptide and a process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7605853A SE399252B (sv) 1976-05-24 1976-05-24 Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin

Publications (2)

Publication Number Publication Date
SE7605853L SE7605853L (sv) 1977-11-25
SE399252B true SE399252B (sv) 1978-02-06

Family

ID=20327976

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7605853A SE399252B (sv) 1976-05-24 1976-05-24 Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin

Country Status (5)

Country Link
JP (1) JPS537693A (fr)
BE (1) BE854968A (fr)
DE (1) DE2723453C2 (fr)
GB (1) GB1539317A (fr)
SE (1) SE399252B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS572382Y2 (fr) * 1978-05-30 1982-01-14
PH21037A (en) * 1984-03-07 1987-06-30 Smithkline Beckman Corp Des-proline vasopressin antagonists
AT398766B (de) * 1988-05-26 1995-01-25 Gebro Broschek Gmbh Verfahren zur intramolekularen oxidation von zwei -sh gruppen in einer peptidverbindung zu einer disulfidbrücke
JPH0469063U (fr) * 1990-10-25 1992-06-18
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
JO3371B1 (ar) * 2013-07-26 2019-03-13 Ferring Bv ناهضات مستقبل فاسوبريسين 2
EP3933244B1 (fr) * 2020-06-30 2024-07-31 TI Automotive (Fuldabrück) GmbH Connecteur rapide avec libération par un outil

Also Published As

Publication number Publication date
DE2723453C2 (de) 1985-07-25
SE7605853L (sv) 1977-11-25
DE2723453A1 (de) 1977-12-15
BE854968A (fr) 1977-09-16
JPS537693A (en) 1978-01-24
GB1539317A (en) 1979-01-31
JPS6131120B2 (fr) 1986-07-17

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO149883C (no) Fremgangsmaate for fremstilling av hydrogenperoksyd
SE7700032L (sv) Framstellning av n-fosfonometylglysin
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
SE427838B (sv) Forfarande for framstellning av aromatiska uretaner
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE7713384L (sv) Forfarande for framstellning av formade cellulosaalster
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE399252B (sv) Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE432765B (sv) Forfarande for framstellning av 2,9-dioxatricyklo/4,3,1,0?723?72,?727/dekaner
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7705447L (sv) Forfarande for framstellning av tioetrar
SE443143B (sv) Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7605853-6

Effective date: 19911209

Format of ref document f/p: F